Cargando…
Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD
The deubiquitinase CYLD acts as a key negative regulator to tightly control overactive inflammation. Most anti-inflammatory strategies have focused on directly targeting the positive regulator, which often results in significant side effects such as suppression of the host defence response. Here, we...
Autores principales: | Komatsu, Kensei, Lee, Ji-Yun, Miyata, Masanori, Hyang Lim, Jae, Jono, Hirofumi, Koga, Tomoaki, Xu, Haidong, Yan, Chen, Kai, Hirofumi, Li, Jian-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644066/ https://www.ncbi.nlm.nih.gov/pubmed/23575688 http://dx.doi.org/10.1038/ncomms2674 |
Ejemplares similares
-
Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice
por: Lim, Jae Hyang, et al.
Publicado: (2007) -
CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt
por: Lim, Jae Hyang, et al.
Publicado: (2012) -
CYLD Negatively Regulates Nontypeable Haemophilus influenzae-Induced IL-8 Expression via Phosphatase MKP-1-Dependent Inhibition of ERK
por: Wang, Wenzhuo Y., et al.
Publicado: (2014) -
Mutual regulation between deubiquitinase CYLD and retroviral oncoprotein Tax
por: Wu, Xuefeng, et al.
Publicado: (2011) -
The E3 ligase Itch and deubiquitinase Cyld co-operatively regulate Tak1 and inflammation
por: Ahmed, Neesar, et al.
Publicado: (2011)